Serum testosterone level predicts the effective time of androgen deprivation therapy in metastatic prostate cancer patients
Androgen deprivation therapy (ADT) is the standard of care for patients with metastatic prostate cancer. However, whether serum testosterone levels, using a cut-off point of 50 ng dl−1 , are related to the effective time of ADT in newly diagnosed prostate cancer patients remains controversial. Moreo...
| Main Authors: | , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wolters Kluwer Medknow Publications
2017-01-01
|
| Series: | Asian Journal of Andrology |
| Subjects: | |
| Online Access: | http://www.ajandrology.com/article.asp?issn=1008-682X;year=2017;volume=19;issue=2;spage=178;epage=183;aulast=Wang |